In the Original Investigation titled “Clinical Characteristics Associated With Response to Biologics in the Treatment of Psoriasis: A Meta-Analysis,”1 published online June 18, 2024, and in the August 2024 issue there was an error in the Discussion section regarding the dosage of biologics by weight. In addition, in eTable 2 in Supplement 1 the reSURFACE 1 and reSURFACE 2 clinical trials were each double-blinded, not quadruple-blinded as previously stated. This article was corrected online.
Reference
- 1.Hjort G, Schwarz CW, Skov L, Loft N. Clinical characteristics associated with response to biologics in the treatment of psoriasis: a meta-analysis. JAMA Dermatol. 2024;160(8):830-837. doi: 10.1001/jamadermatol.2024.1677 [DOI] [PMC free article] [PubMed] [Google Scholar]
